Psoriatic Arthritis

Latest News

Baseline Characteristics Associated With Response to Biologic Therapy in PsA

Baseline Characteristics Associated With Response to Biologic Therapy in PsA

Researchers sought to compare baseline characteristics between patients with PsA who achieved and did not achieve minimal disease activity with biologic therapy.

Alternative Measurement of Psoriasis Severity Effective in CZP-Treated Psoriatic Arthritis

Alternative Measurement of Psoriasis Severity Effective in CZP-Treated Psoriatic Arthritis

The outcome measure may be considered a practical alternative to the Psoriasis Area and Severity Index for the measurement of psoriasis severity and response to therapy.

CONTEST Not Superior to PEST Questionnaire for Diagnosing Psoriatic Arthritis

CONTEST Not Superior to PEST Questionnaire for Diagnosing Psoriatic Arthritis

The CONTEST questionnaire includes the most discriminative questions from the three existing questionnaires.

Low Conversion Rate of Quantiferon-TB Test in TNF Inhibitor-Treated Patients

Low Conversion Rate of Quantiferon-TB Test in TNF Inhibitor-Treated Patients

Investigators sought to determine the rate of conversion of Quantiferon-TB Gold screening test in patients taking anti-TNF therapy.

Power Doppler Ultrasound Abnormalities Evaluated in Psoriatic Arthritis

Power Doppler Ultrasound Abnormalities Evaluated in Psoriatic Arthritis

Researchers sought to evaluate the prevalence rates of peripheral joint, enthesis, tendon, and bursa abnormalities by power Doppler ultrasound in patients with psoriatic arthritis and patients with psoriasis without clinical signs of arthritis.

Incidence of Cardiovascular Events Similar in Rheumatoid Arthritis, Spondyloarthritis

Incidence of Cardiovascular Events Similar in Rheumatoid Arthritis, Spondyloarthritis

The incidence of adverse cardiovascular events in patients with RA do not differ significantly compared with those with PsA or axSpA.

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

Researchers sought to provide information on pregnancy outcomes, including major congenital malformations and other maternal and fetal adverse outcomes, in women treated with certolizumab pegol.

Comparing Burden of Psoriatic Arthritis With Different Definitions of Disease Activity

Comparing Burden of Psoriatic Arthritis With Different Definitions of Disease Activity

Researchers aimed to compare the disease burden of patients with psoriatic arthritis with low disease activity according to 2 definitions.

Etanercept Monotherapy vs Combination Therapy Examined in Psoriatic Arthritis

Etanercept Monotherapy vs Combination Therapy Examined in Psoriatic Arthritis

Etanercept in combination with a conventional synthetic DMARD did not substantially improve clinical response compared with etanercept monotherapy in patients with psoriatic arthritis.

Biosimilar Etanercept SB4 May Decrease Disease Activity in Inflammatory Rheumatic Disease

Biosimilar Etanercept SB4 May Decrease Disease Activity in Inflammatory Rheumatic Disease

Nonmandatory transitioning from originator etanercept to biosimilar etanercept SB4 using a specifically designed communication strategy showed a slightly lower persistence rate and smaller decreases in disease activity.

Sign Up for Free e-newsletters